Karachi, GlaxoSmithKline Pakistan Limited informed Pakistan Stock Exchange that Annual Report of the Company for the year ended December 31, 2018 have been transmitted through PUCARS and is also available on Company’s website.
Glaxo Smith Kline Pakistan Limited is incorporated in Pakistan as
a limited liability company. The company is engaged in manufacturing and
marketing of research based pharmaceutical and consumer products. The company
is a subsidiary of S.R. One International B.V., Netherlands, whereas its
ultimate parent company is GlaxoSmithKline Plc, UK. The stocks of the company
are quoted on the Karachi and Lahore Stock Exchanges of Pakistan.
The company was created on January 1, 2001 through the merger of SmithKline and
French of Pakistan Limited, Beecham Pakistan Private Limited and Glaxo Wellcome
Pakistan Limited. Some of the pharmaceutical brands produced by the company
include Augmentin, Seretide, Amoxil, Velosef, Zantac and Calpol and renowned
consumer healthcare brands, which include Panadol, Horlicks, Aquafresh,
Macleans and ENO.
The symbol “GLAXO” is being used by the stock exchanges for the shares of
GlaxoSmithKline Pakistan Limited.
